comparemela.com

Latest Breaking News On - Alpha therapy - Page 6 : comparemela.com

CNL and Isotope Technologies Munich sign MoU on developing, producing rarest drug on Earth

CHALK RIVER Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced on Oct. 18…

ITM and CNL Sign Memorandum of Understanding to Pursue Global Development and Production of Rare Medical Radioisotope, Actinium-225

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories , Canada’s premier nuclear science and technology organization, today.

IONETIX Announces Targeted Alpha Therapy Manufacturing Center

IONETIX Announces Targeted Alpha Therapy Manufacturing Center News provided by Share this article Share this article LANSING, Mich., March 16, 2021 /PRNewswire/ IONETIX, a leading cyclotron technology and isotope manufacturing company, has acquired a 10,300 sq. ft. facility in Lansing, MI for its new Targeted Alpha Radionuclide Manufacturing Center. The company is in the process of equipping the site for full cGMP drug manufacturing capabilities including a 30 MeV cyclotron unit for alpha radionuclide production to support pre-clinical research, drug development, and early stage clinical trials. IONETIX is currently developing a 30MeV cyclotron utilizing the same proprietary cyclotron technology platform employed in their ION 12SC cyclotron.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.